查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589497

数位偏头痛治疗设备市场：按产品类型、应用划分 - 2025-2030 年全球预测

Digital Migraine Treatment Devices Market by Product Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年数位偏头痛治疗市值为3.8571亿美元，预计到2024年将达到4.3192亿美元，复合年增长率为12.07%，到2030年将达到8.5672亿美元。

数位偏头痛治疗设备是一种创新的医疗保健解决方案，旨在利用神经调节和生物回馈疗法等技术，透过非药物干预来缓解偏头痛症状。这些设备是传统药物疗法的非侵入性治疗方法，透过电、磁或热刺激改变大脑活动，旨在治疗偏头痛。由于偏头痛的盛行率不断上升以及对比传统药物副作用较少的治疗方法的需求，对这些设备的需求正在增加。这些设备主要应用于疼痛管理和神经治疗，对于慢性和阵发性偏头痛患者至关重要。最终用户包括医疗机构、采用远端保健解决方案的个人消费者以及健康诊所。

主要市场统计
基准年[2023] 38571万美元
预测年份 [2024] 43192万美元
预测年份 [2030] 85672万美元
复合年增长率（%） 12.07%

市场成长的主要影响因素包括数位健康解决方案意识的提高、技术进步和个人化医疗的推广。潜在的市场机会来自越来越多地采用具有用户友好界面的携带式和可穿戴设备，并与行动医疗应用程式整合以进行即时追踪和资料分析。关键的成长机会之一是扩大全球意识宣传活动以及医疗保健提供者和高科技公司之间的伙伴关係，以提高产品的可及性和教育水平。然而，市场限制包括高昂的设备成本、监管挑战、有限的保险范围以及与传统治疗相比疗效的怀疑。此外，技术故障和资料隐私问题也可能是一个挑战。

创新机会在于人工智慧和机器学习的交叉点，旨在预测偏头痛模式并客製化干预措施。新的研究领域包括调查数位设备与药物治疗相结合的有效性以及提高设备的易用性和舒适度。为了实现业务成长，公司正在投资强大的临床试验来建立疗效，寻求与健康科技公司的策略联盟，并确保市场的渗透率良好，例如亚洲和拉丁美洲的部分地区。这个市场的本质是动态的，技术进步和消费者健康意识推动着综合健康管理解决方案的发展。

市场动态：快速发展的数位偏头痛治疗设备市场的关键市场洞察

数位偏头痛治疗市场正在因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 偏头痛患者增加
    • 对微创治疗的需求
    • 增加医疗支出以提高服务能力
  • 市场限制因素
    • 处理设备高成本
  • 市场机会
    • 数位偏头痛治疗设备的技术进步
    • 穿戴式装置的成长趋势
  • 市场挑战
    • 限制取得和取得先进设备

波特五力：驾驭数位偏头痛治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解数位偏头痛治疗设备市场的外部影响

外部宏观环境因素在塑造数位偏头痛治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解数位偏头痛治疗设备市场的竞争状况

对数位偏头痛治疗设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵数位偏头痛治疗设备市场供应商的绩效评估

FPNV 定位矩阵是评估数位偏头痛治疗设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘数位偏头痛治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对数位偏头痛治疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 偏头痛盛行率增加
      • 对微创治疗方法的需求
      • 增加医疗费用以提高服务能力
    • 抑制因素
      • 处理设备高成本
    • 机会
      • 数位偏头痛治疗设备的技术进步
      • 穿戴式装置的成长趋势
    • 任务
      • 存取或使用高级设备受到限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章数位偏头痛治疗设备市场：依产品类型

  • 枕神经刺激数位偏头痛治疗仪
  • 单脉衝经颅磁刺激数位化偏头痛治疗仪
  • 眶上刺激数位化偏头痛治疗仪
  • 迷走神经刺激数位偏头痛治疗仪

第七章数位偏头痛治疗设备市场：依应用分类

  • 医院
  • 专科诊所

第八章北美和南美数位偏头痛治疗设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太地区数位偏头痛治疗设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲数位偏头痛治疗设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Allodynic Therapeutics, LLC
  • Amgen Inc.
  • Bayer AG
  • Cefaly Technology
  • Cirrus Healthcare Products
  • electroCore, Inc
  • Eli Lilly and Company
  • eNeura Inc.
  • GlaxoSmithKline plc.
  • Neurolief Ltd.
  • Neuros Medical, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Salvia BioElectronics BV
  • Theranica Bio-Electronics Ltd.
Product Code: MRR-FB6C9E792BE4

The Digital Migraine Treatment Devices Market was valued at USD 385.71 million in 2023, expected to reach USD 431.92 million in 2024, and is projected to grow at a CAGR of 12.07%, to USD 856.72 million by 2030.

Digital migraine treatment devices are innovative healthcare solutions designed to alleviate migraine symptoms through non-pharmacological interventions, utilizing technologies like neuromodulation and biofeedback. These devices offer a non-invasive alternative to traditional medication, targeting migraine treatment via electrical, magnetic, or thermal stimulation to modify brain activity. The necessity of these devices is growing, driven by the increasing prevalence of migraines and the demand for treatments with fewer side effects compared to conventional drugs. They're primarily applied in pain management and neurological therapies, crucial for both chronic and episodic migraine sufferers. End-users span across healthcare facilities, individual consumers adopting telehealth solutions, and wellness clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 385.71 million
Estimated Year [2024] USD 431.92 million
Forecast Year [2030] USD 856.72 million
CAGR (%) 12.07%

Key market growth influences include rising awareness of digital health solutions, advancements in technology, and the push for personalized medicine. Potential market opportunities stem from the increasing adoption of portable and wearable devices with user-friendly interfaces and integration with mobile health apps for real-time tracking and data analysis. One significant growth opportunity is expanding global awareness campaigns and partnerships between healthcare providers and tech companies to enhance product accessibility and education. However, market limitations include high device costs, regulatory challenges, limited insurance coverage, and skepticism regarding their efficacy compared to traditional treatments. Additionally, technological malfunctions and data privacy concerns can pose challenges.

Innovation opportunities lie at the intersection of AI and machine learning, aiming to predict migraine patterns and tailor interventions. Emerging research areas include exploring the efficacy of combining digital devices with pharmacotherapy and improving the comfort and ease of device use. For business growth, companies should invest in robust clinical trials to establish efficacy, seek strategic collaborations with health tech firms, and focus on regions with underpenetrated markets like parts of Asia and Latin America. The nature of this market is dynamic, with technology advancements and consumer health awareness driving its evolution towards integrated health management solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Migraine Treatment Devices Market

The Digital Migraine Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of migraine patients
    • Demand for less invasive therapeutics
    • Growing healthcare expenditure on improving their service capabilities
  • Market Restraints
    • High cost of treatment devices
  • Market Opportunities
    • Technology advancements in the digital migraine treatment devices
    • Increasing trend of wearable devices
  • Market Challenges
    • Limited access or availability to advanced devices

Porter's Five Forces: A Strategic Tool for Navigating the Digital Migraine Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Migraine Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Migraine Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Migraine Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Migraine Treatment Devices Market

A detailed market share analysis in the Digital Migraine Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Migraine Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Migraine Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Migraine Treatment Devices Market

A strategic analysis of the Digital Migraine Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Migraine Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Allodynic Therapeutics, LLC, Amgen Inc., Bayer AG, Cefaly Technology, Cirrus Healthcare Products, electroCore, Inc, Eli Lilly and Company, eNeura Inc., GlaxoSmithKline plc., Neurolief Ltd., Neuros Medical, Inc., Novartis AG, Pfizer Inc., Salvia BioElectronics B.V., and Theranica Bio-Electronics Ltd..

Market Segmentation & Coverage

This research report categorizes the Digital Migraine Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Occipital Nerve Stimulation Digital Migraine Treatment Devices, Single-pulse Transcranial Magnetic Stimulation Digital Migraine Treatment Devices, Supraorbital Stimulation Digital Migraine Treatment Devices, and Vagus Nerve Stimulation Digital Migraine Treatment Devices.
  • Based on Application, market is studied across Hospitals and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of migraine patients
      • 5.1.1.2. Demand for less invasive therapeutics
      • 5.1.1.3. Growing healthcare expenditure on improving their service capabilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology advancements in the digital migraine treatment devices
      • 5.1.3.2. Increasing trend of wearable devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited access or availability to advanced devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Migraine Treatment Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Occipital Nerve Stimulation Digital Migraine Treatment Devices
  • 6.3. Single-pulse Transcranial Magnetic Stimulation Digital Migraine Treatment Devices
  • 6.4. Supraorbital Stimulation Digital Migraine Treatment Devices
  • 6.5. Vagus Nerve Stimulation Digital Migraine Treatment Devices

7. Digital Migraine Treatment Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Clinics

8. Americas Digital Migraine Treatment Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Migraine Treatment Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Migraine Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allodynic Therapeutics, LLC
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. Cefaly Technology
  • 5. Cirrus Healthcare Products
  • 6. electroCore, Inc
  • 7. Eli Lilly and Company
  • 8. eNeura Inc.
  • 9. GlaxoSmithKline plc.
  • 10. Neurolief Ltd.
  • 11. Neuros Medical, Inc.
  • 12. Novartis AG
  • 13. Pfizer Inc.
  • 14. Salvia BioElectronics B.V.
  • 15. Theranica Bio-Electronics Ltd.

LIST OF FIGURES

  • FIGURE 1. DIGITAL MIGRAINE TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL MIGRAINE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL MIGRAINE TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY OCCIPITAL NERVE STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SINGLE-PULSE TRANSCRANIAL MAGNETIC STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SUPRAORBITAL STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. DIGITAL MIGRAINE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023